PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM) — FDA Approval ANDA219087 (GRAVITI PHARMS)
PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM) — FDA Approval ANDA219087 (GRAVITI PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: PANTOPRAZOLE SODIUM; Active ingredients: PANTOPRAZOLE SODIUM; Application number: ANDA219087.
| Brand name | PANTOPRAZOLE SODIUM |
|---|---|
| Active ingredients | PANTOPRAZOLE SODIUM |
| Application number | ANDA219087 |
| Sponsor | GRAVITI PHARMS |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20250116 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →